PTAB statistics

PTAB Trial Statistics as of January 31, 2017

As of January 31, 2017, USPTO records show 6,396 AIA trial petitions filed since September 16, 2012 (5,828 IPR, 504 CBM, 48 PGR, 16 derivation). The Board had instituted trial on 3,043 petitions and denied 2,031 (60.0% instituted) and had issued 1,648 final written decisions. In fiscal year 2017 to that date, 726 petitions were filed.

Key Facts

As of
January 31, 2017
Fiscal year
FY2017
Petitions filed (cumulative)
6,396
Institution rate (cumulative)
60.0%
Petitions filed (FY2017 to date)
726
Data retrieved
October 31, 2026
On this page
  1. Cumulative Figures as of January 31, 2017
  2. Fiscal Year 2017 to Date
  3. Change Since September 30, 2016
  4. Trial Types Covered
  5. How These Figures Were Compiled
  6. Related Statistics

This page gives Patent Trial and Appeal Board trial figures as of January 31, 2017, which falls in fiscal year 2017 (October 1, 2016 to September 30, 2017). The cumulative figures run from September 16, 2012, when AIA trials began. The full year is covered on the FY2017 statistics page.

Cumulative Figures as of January 31, 2017

Events from September 16, 2012 to January 31, 2017, by trial type:

MeasureIPRPGRCBMDERTotal
Petitions filed5,82848504166,396
Institution decisions: instituted2,7541527403,043
Institution decisions: denied1,8351317942,031
Institution rate (by petition)60.0%53.6%60.5%0.0%60.0%
Final written decisions1,477916201,648
Terminations without a final written decisionCount
Settlements853
Adverse judgment0
Dismissed0
Other terminations154

Fiscal Year 2017 to Date

Events from October 1, 2016 to January 31, 2017:

MeasureIPRPGRCBMDERTotal
Petitions filed68511282726
Institution decisions: instituted2351110247
Institution decisions: denied1454111161
Institution rate (by petition)61.8%20.0%50.0%0.0%60.5%
Final written decisions2266100242
Terminations without a final written decisionCount
Settlements154
Settled before institution82
Settled after institution72
Adverse judgment0
Dismissed0
Other terminations53

Change Since September 30, 2016

Between the previous dated page (September 30, 2016) and January 31, 2017, 726 petitions were filed, 247 trials were instituted, 161 petitions were denied institution and 242 final written decisions issued. The cumulative institution rate moved from 59.9% to 60.0%.

Trial Types Covered

5,828 of the 6,396 petitions (91.1%) were for inter partes review, which challenges patent claims on prior-art grounds under 35 U.S.C. chapter 31. The remainder were for covered business method review (504), post-grant review under chapter 32 (48) and derivation proceedings (16). Institution standards differ by proceeding; see the threshold standards.

How These Figures Were Compiled

The figures are counted from USPTO Open Data Portal records retrieved on October 31, 2026, keeping only events dated on or before January 31, 2017: a petition by its filing date, an institution decision by its decision date, and a final written decision or termination by its date. They are a reconstruction from the current records, not the USPTO’s report of that date, and may differ from statistics the USPTO published at the time. Final written decision outcomes are not reported because the records state them for too few decisions. The methodology gives the counting rules in full.

Frequently Asked Questions

How many AIA trial petitions had been filed as of January 31, 2017?

USPTO records show 6,396 petitions filed from September 16, 2012 to January 31, 2017: 5,828 IPR, 504 CBM, 48 PGR and 16 derivation.

What was the PTAB institution rate as of January 31, 2017?

Cumulatively, 60.0% by petition: 3,043 instituted and 2,031 denied. In FY2017 to that date the rate was 60.5%.

Primary Sources

  1. USPTO Open Data Portal (PTAB trial proceedings and decisions data)
  2. USPTO Patent Trial and Appeal Board statistics
  3. 35 U.S.C. chapter 31 (inter partes review)
  4. 35 U.S.C. chapter 32 (post-grant review)
  5. 37 C.F.R. Part 42 (trial practice before the PTAB)

Educational information; not legal advice. Statutes, rules and USPTO practice change. Confirm against the primary sources and consult a registered patent practitioner before acting. Disclaimer.